BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1092 related articles for article (PubMed ID: 26140494)

  • 1. Operative wound-related complications after cranial revascularization surgeries.
    Takanari K; Araki Y; Okamoto S; Sato H; Yagi S; Toriyama K; Yokoyama K; Murotani K; Matsui S; Wakabayashi T; Kamei Y
    J Neurosurg; 2015 Nov; 123(5):1145-50. PubMed ID: 26140494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of encephalo-myo-synangiosis in surgical revascularization strategies for moyamoya disease in children and adults.
    Imai H; Miyawaki S; Ono H; Nakatomi H; Yoshimoto Y; Saito N
    World Neurosurg; 2015 May; 83(5):691-9. PubMed ID: 25655688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superficial temporal artery-to-middle cerebral artery anastomosis with encephalo-duro-myo-synangiosis as a modified operative procedure for moyamoya disease.
    Ishii K; Morishige M; Anan M; Sugita K; Abe E; Kubo T; Fujiki M; Kobayashi H
    Acta Neurochir Suppl; 2010; 107():95-9. PubMed ID: 19953378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Navigation-guided clipping of a de novo aneurysm associated with superficial temporal artery-middle cerebral artery bypass combined with indirect pial synangiosis in a patient with moyamoya disease.
    Aburakawa D; Fujimura M; Niizuma K; Sakata H; Endo H; Tominaga T
    Neurosurg Rev; 2017 Jul; 40(3):517-521. PubMed ID: 28555327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical results in pediatric moyamoya disease: angiographic revascularization and the clinical results.
    Kim DS; Kang SG; Yoo DS; Huh PW; Cho KS; Park CK
    Clin Neurol Neurosurg; 2007 Feb; 109(2):125-31. PubMed ID: 16872739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superficial temporal artery-to-middle cerebral artery bypass in combination with indirect revascularization in moyamoya patients ≤ 3 years of age.
    Bot GM; Burkhardt JK; Gupta N; Lawton MT
    J Neurosurg Pediatr; 2018 Nov; 23(2):198-203. PubMed ID: 30497164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "STA-MCA bypass with encephalo-duro-myo-synangiosis combined with bifrontal encephalo-duro-periosteal-synangiosis" as a one-staged revascularization strategy for pediatric moyamoya vasculopathy.
    Esposito G; Kronenburg A; Fierstra J; Braun KP; Klijn CJ; van der Zwan A; Regli L
    Childs Nerv Syst; 2015 May; 31(5):765-72. PubMed ID: 25722049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wound healing complications after revascularization for moyamoya vasculopathy with reference to different skin incisions.
    Acker G; Schlinkmann N; Fekonja L; Grünwald L; Hardt J; Czabanka M; Vajkoczy P
    Neurosurg Focus; 2019 Feb; 46(2):E12. PubMed ID: 30717062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical efficacy of different vascular reconstruction on adult moyamoya disease].
    Pan SJ; Zhang Y; Hou Y; Wang JF; Chai HF; Zhao ZX; Hu XM; Zang YZ
    Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(13):998-1002. PubMed ID: 30955312
    [No Abstract]   [Full Text] [Related]  

  • 10. Late (5-20 years) outcomes after STA-MCA anastomosis and encephalo-duro-myo-arterio-pericranial synangiosis in patients with moyamoya disease.
    Kuroda S; Nakayama N; Yamamoto S; Kashiwazaki D; Uchino H; Saito H; Hori E; Akioka N; Kuwayama N; Houkin K
    J Neurosurg; 2020 Mar; 134(3):909-916. PubMed ID: 32168480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superficial temporal artery-middle cerebral artery bypass combined with encephalo-duro-myo-synangiosis in treating moyamoya disease: surgical techniques, indications and midterm follow-up results.
    Xu B; Song DL; Mao Y; Gu YX; Xu H; Liao YJ; Liu CH; Zhou LF
    Chin Med J (Engl); 2012 Dec; 125(24):4398-405. PubMed ID: 23253709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indirect revascularization techniques for treating moyamoya disease.
    Patel NN; Mangano FT; Klimo P
    Neurosurg Clin N Am; 2010 Jul; 21(3):553-63. PubMed ID: 20561503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-operative higher hematocrit and lower total protein levels are independent risk factors for cerebral hyperperfusion syndrome after superficial temporal artery-middle cerebral artery anastomosis with pial synangiosis in adult moyamoya disease patients-case-control study.
    Katsuki M; Fujimura M; Tashiro R; Tomata Y; Nishizawa T; Tominaga T
    Neurosurg Rev; 2021 Aug; 44(4):2191-2200. PubMed ID: 32968846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative middle cerebral artery pressure measurements during superficial temporal artery to middle cerebral artery bypass procedures in patients with cerebral atherosclerotic disease.
    Matano F; Murai Y; Tanikawa R; Kamiyama H; Tateyama K; Tamaki T; Mizunari T; Mizumura S; Kobayashi S; Teramoto A; Morita A
    J Neurosurg; 2016 Dec; 125(6):1367-1373. PubMed ID: 26943849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective surgical revascularization improves cerebral hemodynamics and resolves headache in pediatric Moyamoya disease.
    Kawabori M; Kuroda S; Nakayama N; Hirata K; Shiga T; Houkin K; Tamaki N
    World Neurosurg; 2013 Nov; 80(5):612-9. PubMed ID: 23022638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.
    Fujimura M; Mugikura S; Kaneta T; Shimizu H; Tominaga T
    Surg Neurol; 2009 Apr; 71(4):442-7. PubMed ID: 18514264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease.
    Fujimura M; Niizuma K; Inoue T; Sato K; Endo H; Shimizu H; Tominaga T
    Neurosurgery; 2014 Feb; 74(2):163-70; discussion 170. PubMed ID: 24176958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and Risk Factors of the Watershed Shift Phenomenon after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis for Adult Moyamoya Disease.
    Tashiro R; Fujimura M; Kameyama M; Mugikura S; Endo H; Takeuchi Y; Tomata Y; Niizuma K; Tominaga T
    Cerebrovasc Dis; 2019; 47(3-4):178-187. PubMed ID: 31121577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in cerebral hemodynamic parameters and outcomes after superficial temporal artery-middle cerebral artery bypass in patients with severe stenoocclusive disease of the intracranial internal carotid or middle cerebral arteries.
    Low SW; Teo K; Lwin S; Yeo LL; Paliwal PR; Ahmad A; Sinha AK; Teoh HL; Wong LY; Chong VF; Seet RC; Chan BP; Yeo TT; Chou N; Sharma VK
    J Neurosurg; 2015 Sep; 123(3):662-9. PubMed ID: 26023999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enlarged Encephalo-Duro-Myo-Synangiosis Treatment for Moyamoya Disease in Young Children.
    Shen W; Xu B; Li H; Gao X; Liao Y; Shi W; Zhao R; Zhang Y
    World Neurosurg; 2017 Oct; 106():9-16. PubMed ID: 28645592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.